Development of Cellular Tools and Techniques to Identify Low Affinity T Cells
开发识别低亲和力 T 细胞的细胞工具和技术
基本信息
- 批准号:9974912
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-09 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAffinityAntigen-Presenting CellsAntigensBaculovirusesBasic ScienceBenchmarkingBindingBiological AssayCD4 Positive T LymphocytesCell LineCellsCellular ImmunityCellular biologyCommunitiesComplexCoupledCouplingDataDetectionEngineeringEpitopesFailureFrequenciesGene Expression ProfilingGenerationsGenetic TranscriptionGoalsHistocompatibilityImmunityImmunologyInfectionInsectaKnowledgeLigandsLymphomaMajor Histocompatibility ComplexMalignant NeoplasmsMammalian CellMethodsMolecular BiologyOVA 323-339PaperPeptide/MHC ComplexPeptidesPhenotypePopulationProcessProductionProtocols documentationPublishingReagentRecombinantsResearchResearch PersonnelResearch ProposalsStainsSurveysT cell responseT-Cell Immunologic SpecificityT-Cell ReceptorT-LymphocyteTechniquesTechnologyTestingVariantWest Nile virusWorkadaptive immunitycellular developmentcytokinedesignenzyme linked immunospot assayin vivoinsightmicrobialmonomerpreventresponsetissue culturetool
项目摘要
PROJECT SUMMARY
Each naïve cell within the T cell repertoire expresses a unique T cell receptor (TCR) that allows it to recognize
peptide antigens in the context of major histocompatibility (pMHC) molecules. TCR-pMHC interactions are the
chief determinants of long-lived adaptive immunity against microbial infections and cancer. The use of pMHC
tetramers to identify and study T cells expressing TCRs of high affinity for their cognate ligand has been
transformational for our understanding of T cell-mediated immunity. However, problems with their production
and a failure of these reagents to detect T cells expressing low affinity TCRs have led to significant limits on
our knowledge of T cell responses. Here we propose to develop a technique that can be readily used to make
a broad range of pMHC and detect T cells expressing TCRs of low affinity for their cognate pMHC.
项目总结
T细胞库中的每个幼稚细胞都表达一种独特的T细胞受体(TCR),使其能够识别
主要组织相容性(PMHC)分子背景下的多肽抗原。TCR-pMHC相互作用是
针对微生物感染和癌症的长寿适应性免疫的主要决定因素。PMHC的使用
四聚体用于鉴定和研究表达与其同源配体高亲和力的TCR的T细胞
对我们理解T细胞介导的免疫具有变革性。然而,他们的生产问题
而这些试剂未能检测到表达低亲和力TCR的T细胞,导致了对
我们对T细胞反应的了解。在这里,我们建议开发一种技术,可以很容易地用于制造
广泛的pMHC和检测T细胞表达与其同源pMHC低亲和力的TCR。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael S Kuhns其他文献
Michael S Kuhns的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael S Kuhns', 18)}}的其他基金
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes
设计第二代 5MCAR 来监测和治疗 I 型糖尿病
- 批准号:
10598106 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Engineering and Testing of Biomimetic Stimulators for Therapeutic Applications
用于治疗应用的仿生刺激器的工程和测试
- 批准号:
10705808 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Adapting 5MCAR technology for the treatment of peripheral T cell lymphoma
采用5MCAR技术治疗外周T细胞淋巴瘤
- 批准号:
10351121 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Engineering and Testing of Biomimetic Stimulators for Therapeutic Applications
用于治疗应用的仿生刺激器的工程和测试
- 批准号:
10570359 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes
设计第二代 5MCAR 来监测和治疗 I 型糖尿病
- 批准号:
10435625 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Adapting 5MCAR technology for the treatment of peripheral T cell lymphoma
采用5MCAR技术治疗外周T细胞淋巴瘤
- 批准号:
10543167 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Inducing Tolerance with 5-Module chimeric Antigen Receptor (5MCAR) T Cells
使用 5 模块嵌合抗原受体 (5MCAR) T 细胞诱导耐受
- 批准号:
10247395 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Development of Cellular Tools and Techniques to Identify Low Affinity T Cells
开发识别低亲和力 T 细胞的细胞工具和技术
- 批准号:
10259675 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Probing the mechanistic basis for T cell fate decisions (R01)
探讨T细胞命运决定的机制基础(R01)
- 批准号:
8702920 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
Probing the mechanistic basis for T cell fate decisions (R01)
探讨T细胞命运决定的机制基础(R01)
- 批准号:
10088367 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Continuing Grant